Connection

Jacques Izopet to Middle Aged

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Middle Aged.
Jacques Izopet
Connection Strength
0.151
Middle Aged
  1. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 06 15; 11(1):12597.
    View in: PubMed
    Score: 0.015
  2. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8.
    View in: PubMed
    Score: 0.015
  3. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. J Clin Virol. 2020 08; 129:104541.
    View in: PubMed
    Score: 0.014
  4. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017 07; 23(7):1191-1193.
    View in: PubMed
    Score: 0.012
  5. Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens. Emerg Infect Dis. 2017 05; 23(5):863-865.
    View in: PubMed
    Score: 0.011
  6. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):25-27.
    View in: PubMed
    Score: 0.011
  7. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010 Mar 01; 50(5):e30-3.
    View in: PubMed
    Score: 0.007
  8. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Antivir Ther. 2008; 13(4):537-45.
    View in: PubMed
    Score: 0.006
  9. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
    View in: PubMed
    Score: 0.004
  10. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.003
  11. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfus Med Rev. 2019 07; 33(3):146-153.
    View in: PubMed
    Score: 0.003
  12. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother. 2019 05 01; 74(5):1417-1424.
    View in: PubMed
    Score: 0.003
  13. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 04; 21(2):e13050.
    View in: PubMed
    Score: 0.003
  14. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 11 28; 67(12):1883-1889.
    View in: PubMed
    Score: 0.003
  15. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
    View in: PubMed
    Score: 0.003
  16. Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study. Transplantation. 2018 08; 102(8):1351-1357.
    View in: PubMed
    Score: 0.003
  17. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.003
  18. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.003
  19. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transpl Infect Dis. 2018 Aug; 20(4):e12917.
    View in: PubMed
    Score: 0.003
  20. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 03 01; 73(3):738-747.
    View in: PubMed
    Score: 0.003
  21. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.003
  22. Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine (Baltimore). 2017 Sep; 96(39):e7915.
    View in: PubMed
    Score: 0.003
  23. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017 Aug 29; 89(9):909-917.
    View in: PubMed
    Score: 0.003
  24. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017 11; 67(5):925-932.
    View in: PubMed
    Score: 0.003
  25. Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
    View in: PubMed
    Score: 0.003
  26. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. J Antimicrob Chemother. 2017 06 01; 72(6):1769-1773.
    View in: PubMed
    Score: 0.003
  27. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016 09; 9(5):1137-50.
    View in: PubMed
    Score: 0.003
  28. Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology. 2002 Nov; 123(5):1494-9.
    View in: PubMed
    Score: 0.001
  29. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995 May 27; 59(10):1426-31.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.